Shape Therapeutics Welcomes Google and Stripe Veterans Gayathri Rajan, Kelly Sims to its Board of Directors
April 26, 2022 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, April 26, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc., the RNA technology company advancing programmable medicine, today announced the addition of two new members to its board of...
Shape Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 06, 2022 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company creating the future of RNA technologies, today announced that Francois Vigneault, PhD.,...
Shape Therapeutics Appoints David J. Huss, Ph.D., as Chief Scientific Officer and Lisa Taylor Ash, J.D., as General Counsel
November 09, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment...
Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications
August 24, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target...
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
July 15, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion...
UPDATE – Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
May 28, 2021 20:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, May 28, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced that...
Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
May 25, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, May 25, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced that...
Shape Therapeutics Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 04, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced two abstracts...
Shape Therapeutics Welcomes Patrick Bigot as its Chief Business Officer
April 20, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the...